Sign In
Buy PTC
$139.72
-2.62 (-1.84%)
At Close: Jun 03, 2026
PTC Inc. (PTC) Surpasses Q2 Earnings and Revenue Estimates
06:25pm, Wednesday, 06'th May 2026
PTC Inc. (PTC) came out with quarterly earnings of $2.69 per share, beating the Zacks Consensus Estimate of $2.06 per share. This compares to earnings of $1.79 per share a year ago.
PTC lifts annual revenue forecast on steady software demand
04:56pm, Wednesday, 06'th May 2026
PTC Inc on Wednesday raised its full-year revenue forecast, citing continued demand from manufacturers using its software to digitize their design and production processes.
PTC ANNOUNCES SECOND FISCAL QUARTER 2026 RESULTS
04:01pm, Wednesday, 06'th May 2026
Strategic focus on Intelligent Product Lifecycle vision Solid execution in Q2'26 Constant currency ARR growth of 8.5% excluding divested businesses Operating and free cash flow growth of 14% ~$625 mil
PTC's Windchill PLM designated by U.S. Army as its Official Enterprise Product Data Management (ePDM) Solution
08:30am, Wednesday, 06'th May 2026
Windchill enables enterprise-scale digital engineering from acquisition to sustainment Streamlines governance and supports modernization, increases availability of essential mission-critical data Allo
PTC to Release Q2 Earnings: Here's What Investors Should Expect
12:00pm, Tuesday, 05'th May 2026
PTC heads into Q2 earnings with double-digit revenue and EPS growth expectations, strong ARR momentum and expanding AI-driven product capabilities.
PTC Codebeamer Replaces Legacy System at Hamilton Medical
08:30am, Tuesday, 05'th May 2026
Collaboration agreement formed to advance market-specific ALM-PLM solutions Codebeamer ALM solution selected to enhance collaboration, validation, traceability, and regulatory compliance across produc
PTC Therapeutics to Participate in Upcoming Investor Conferences
08:00am, Monday, 04'th May 2026
WARREN, N.J., May 4, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: Bank of America Securities Health Care Conf
PTC Therapeutics Stock Sinks As Pivotal Data Fails To Calm Sellers
02:48pm, Wednesday, 29'th Apr 2026
PTC Therapeutics Inc. (NASDAQ:PTCT) shares are tumbling on Wednesday, after the company reported topline results from the 24-month interim analysis of its PIVOT-HD long-term extension study.
PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam
04:05pm, Tuesday, 28'th Apr 2026
- Dose-dependent benefit on cUHDRS in Stage 2 participants compared to matched natural history cohort, with 52% slowing at 10 mg dose - - Continued evidence of favorable safety profile - - Novartis
PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study
09:28am, Tuesday, 28'th Apr 2026
WARREN, N.J., April 28, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call today, April 28 at 4:30 p.m.
PTC Launches Windchill AI Assistant to Simplify How Teams Find and Leverage Product Data Across the Enterprise
08:30am, Tuesday, 28'th Apr 2026
Allows users to ask questions in natural language to quickly find answers through an embedded chat interface Helps teams save time by summarizing and surfacing key details from product documents Appli
PTC Showcases Bobcat's Use of the Intelligent Product Lifecycle at Hannover Messe 2026
08:30am, Wednesday, 22'nd Apr 2026
MUNICH, April 22, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) PTC today announced it will demonstrate how Bobcat, a leading global manufacturer of compact equipment, can leverage the Intelligent Product L
PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
08:00am, Wednesday, 22'nd Apr 2026
WARREN, N.J., April 22, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its first quarter 2026 financial resul
Massachusetts Financial Services Co. MA Has $483,000 Position in PTC Inc. $PTC
04:58am, Sunday, 19'th Apr 2026
Massachusetts Financial Services Co. MA reduced its position in shares of PTC Inc. (NASDAQ: PTC) by 98.4% in the undefined quarter, according to the company in its most recent 13F filing with the Secu
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 17'th Apr 2026
WARREN, N.J., April 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 13, 2026, the company approved non-statutory stock options to purchase an aggregate of
